Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NuVision Biotherapies Ltd logo — Amniotic membrane but not as you know it

NuVision Biotherapies Ltd

Amniotic membrane but not as you know it

Founded 2015 United Kingdom Nottingham, United Kingdom 21 employees Venture round Total: $5.89M Biotechnology, Health and Wellness

General Information

Company Name NuVision Biotherapies Ltd
Founded Year 2015
Location United Kingdom Nottingham, United Kingdom
Employees 21
Industries Biotechnology, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with NuVision Biotherapies Ltd. To contact NuVision Biotherapies Ltd, visit nu-vision.co.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About NuVision Biotherapies Ltd

NuVision is a biotechnology startup based in the United Kingdom, founded in 2015. The company's focus is on developing innovative, high-quality, and cost-effective regenerative therapies for ophthalmology and wound care. Their slogan, "Amniotic membrane but not as you know it," reflects their unique approach to utilizing amniotic membrane in their products.

The latest milestone for NuVision was a £1.80M Venture Round investment on 16 July 2021. This funding was secured from a group of investors including Newable Private Investing, MEIF Proof-of-Concept & Early Stage Fund, and Mercia’s EIS funds.

As a spin-out from the University of Nottingham, NuVision is leveraging its strong research and development background to make a significant impact in the biotechnology and health and wellness industries.

Taxonomy: development, spin out company, University of Nottingham, biotech, innovation, technology transfer, startup, investor, biomedical, biopharmaceutical, biotech spinoff, technology commercialization, university spinout

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £1.80M 3
Newable Private Investing MEIF Proof-of-Concept & Early Stage Fund
Newable Private Investing, MEIF Proof-of-Concept & Early Stage Fund +1
16 Jul 2021
Venture Round £1.60M 1
Newable Private Investing
Newable Private Investing
22 Apr 2021
Venture Round £1.40M 3
MEIF Proof-of-Concept & Early Stage Fund
MEIF Proof-of-Concept & Early Stage Fund, University of Nottingham +1
12 Sep 2019
Seed Round £500.00K 2
University of Nottingham, Mercia Fund Managers
08 Feb 2018
Non Equity Assistance Undisclosed 1
Pitch@Palace
Pitch@Palace
25 Apr 2017
Seed Round $590.00K 1
Mercia Fund Managers
31 Jul 2015

NuVision Biotherapies Ltd Alternatives & Competitors

View All Alternatives
NuVision Biotherapies Ltd vs
iQure Pharma Inc.
iQure Pharma Inc. United States

Providing attractive therapies to patients and physicians while ensuring significant return on inves...

Debt Financing
7 employees
Biotechnology, Health and Wellness
NuVision Biotherapies Ltd vs
Amaroq Therapeutics
Amaroq Therapeutics New Zealand

Nothing remains concealed

5 employees
Biotechnology, Health and Wellness
NuVision Biotherapies Ltd vs
Drive Therapeutics
Drive Therapeutics United States

Addressing Unmet Needs in Retinal Therapeutics

Grant
3 employees
Biotechnology, Health Care
View all alternatives

FAQ About NuVision Biotherapies Ltd

Amniotic membrane but not as you know it
NuVision Biotherapies Ltd was founded in 2015.
NuVision Biotherapies Ltd is headquartered in Nottingham, United Kingdom.
NuVision Biotherapies Ltd operates in Biotechnology and Health and Wellness. Its work centres on development, spin out company, University of Nottingham and biotech.
NuVision Biotherapies Ltd has approximately 21 employees.
NuVision Biotherapies Ltd has completed 6 funding rounds, raising a total of $5.89M. The latest funding stage is Venture round.
Top alternatives and competitors to NuVision Biotherapies Ltd include iQure Pharma Inc., Amaroq Therapeutics, Drive Therapeutics, Draupnir Bio, SOLID Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NuVision Biotherapies Ltd and iQure Pharma Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NuVision Biotherapies Ltd, https://bouncewatch.com/company/nuvision, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes